For the first time to our knowledge, we demonstrate that DARPP-32 and its splice variant t-DARPP stimulate lung cancer cell survival and migration to promote oncogenesis, and we show that elevated t-DARPP isoform levels in NSCLC patients are associated with increased tumor staging and worsened patient survival. This evidence concerns the gene PPP1R1B and non-small cell lung carcinoma.